Emerging Markets
Sunhydrogen Inc (OTCMKTS: HYSR) Under Accumulation as Co Provides First Look at Prototype for its Nanoparticle-Based Green Hydrogen Technology
Sunhydrogen Inc (OTCMKTS: HYSR) is hovering over $0.03 as investors wait on another test of $0.051 reached at the end of July. HYSR is a stock with a long history of big moves starting in 2014 and continuing onward with the most recent run up in early 2021 to highs of $0.34 per share. The stock also has a significant shareholder base and when HYSR heats up investors pay attention. The demand for Hydrogen continues to increase at a rapid rate with the current global fuel cell market estimated to be worth $170 billion. Large oil Companies such as BP are also ramping up their hydrogen investments. Currently Hydrogen supplies less than 5% of the World’s energy but some estimates suggest if may represent up to 25% of the Worlds energy by 2050 representing a $2.5 trillion market opportunity. HYSR is very well funded moving forward with about $52 million in cash ($42mm cash) and marketable securities on its balance sheet as of June 30, 2022, a number that instills confidence in its executive and scientific teams alike as the Company continues moving toward the commercialization of its nanoparticle-based green hydrogen technology. SunHydrogen is currently at a critical developmental juncture with the goal of a production-quality prototype set for the end of 2022.
SunHydrogen continues to make progress toward multiple planned 2022 milestones and is on track to demonstrate a production-quality prototype of its nanoparticle-based green hydrogen technology by the end of Q4 2022. Last week the Company provided a first look at the prototype design for its forthcoming nanoparticle-based green hydrogen technology. The images can be viewed by visiting the Company’s news feed. SunHydrogen’s prototype design carefully integrates the Company’s proprietary catalysts, light absorber and membrane integration assembly. The panel housing is built from lightweight, stable, modular materials that are easily scalable for mass manufacturing. Additionally, the design allows for efficient use of sunlight to maximize hydrogen production during the day with minimal water consumption. Once the prototype design is realized, the Company’s scientific team will begin evaluating its performance and individual design elements to ensure efficient hydrogen production and collection.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Sunhydrogen Inc (OTCMKTS: HYSR) is developing a breakthrough, low-cost technology to make renewable hydrogen using sunlight and any source of water, including seawater and wastewater. The only byproduct of hydrogen fuel is pure water, unlike hydrocarbon fuels such as oil, coal and natural gas that release carbon dioxide and other contaminants into the atmosphere when used. By optimizing the science of water electrolysis at the nano-level, our low-cost nanoparticles mimic photosynthesis to efficiently use sunlight to separate hydrogen from water, ultimately producing environmentally friendly renewable hydrogen. Using the Company’s low-cost method to produce renewable hydrogen, HYSR intends to enable a world of distributed hydrogen production for renewable electricity and hydrogen fuel cell vehicles. SunHydrogen started 2022 with the addition of a new research and development laboratory in Coralville, Iowa, to fuel its goal of scaling up fabrication of its nanoparticle hydrogen generator units by the end of the 2022 fiscal year.
The SunHydrogen solution offers an efficient and cost-effective way to produce truly green hydrogen using sunlight and any source of water. The Company’s core technology is a self-contained, nanoparticle-based hydrogen generator that mimics photosynthesis to split water molecules, resulting in hydrogen. By optimizing the science of water electrolysis at the nano-level, HYSR believes it has developed a low-cost method to potentially produce environmentally friendly renewable hydrogen. With a target cost of $2.50/kg., HYSR aspires for its technology to be cost-competitive with brown hydrogen and below the cost of clean hydrogen competitors.
Powered by solar energy, billions of microscopic nanoparticles split apart water at the molecular level, extracting hydrogen for use as a clean energy source and leaving behind only clean oxygen as a byproduct. This process is similar to what happens inside a plant cell during photosynthesis: Each Photoelectrochemically Active Heterostructures (or PAH) nanoparticle is a microscopic machine, composed of multiple layers enabling the solar electrolysis reaction to take place.
HYSR has a growing intellectual property portfolio securing its first patent in 2017 covering the structural design of Photoelectrochemically Active Heterostructures (PAH) US Patent No. 9,593,053B1. In 2018 the Company was issued another patent covering the method for manufacturing PAH US Patent No. 9,593,053B2. Patents covering the Company’s semiconductor designs have been issued in Australia in April of 2018, China and Europe in March of 2019, and in the U.S. as United States Patent No. 10,100,415 in October of 2018. A patent application is currently pending in India. On September 26, 2016, the Company filed jointly with the University of Iowa a provisional application for “Integrated Membrane Solar Fuel Production Assembly.” Also on September 26, 2017, HSYR filed a PCT Application that was later nationalized in the U.S. on March 26, 2019. The U.S. patent application for this important invention is pending and prosecution is ongoing.
The global hydrogen market is large and growing rapidly. Over 110 countries have set goals to achieve net-zero emissions by 2050, and as governments look to clean energy sources to help them meet their targets, hydrogen is emerging as a promising solution. It is estimated that nearly 25% of global energy will come from clean hydrogen alone by 2050 a tenfold increase from today, which could bring in a projected $2.5 trillion in annual revenues (Source: Bank of America Securities, New Energy Behind Green Hydrogen).
https://twitter.com/GonzaleCore/status/1567673538630356993
To Find out the inside Scoop on HYSR Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On September 6 HYSR provided a first look at the prototype design for its forthcoming nanoparticle-based green hydrogen technology. The images can be viewed by visiting the Company’s news feed. SunHydrogen’s prototype design carefully integrates the Company’s proprietary catalysts, light absorber and membrane integration assembly. The panel housing is built from lightweight, stable, modular materials that are easily scalable for mass manufacturing. Additionally, the design allows for efficient use of sunlight to maximize hydrogen production during the day with minimal water consumption.
SunHydrogen’s nanoparticle technology directly uses the electrical charges created by sunlight to generate hydrogen when the Sun is shining. However, when the Sun is not shining, this prototype is also able to power the catalyst and membrane integration assembly using renewable grid electricity from wind or hydropower sources. Once the prototype design is realized, the Company’s scientific team will begin evaluating its performance and individual design elements to ensure efficient hydrogen production and collection.
SunHydrogen’s Chief Scientific Officer Dr. Syed Mubeen stated: “Within an individual SunHydrogen panel, billions of microscopic nanoparticles are splitting apart water at the molecular level to produce hydrogen and oxygen. What you see in the rendered images is a single prototype panel contained in protective housing. In a future hydrogen production plant or farm, our panels would be scaled up in dimension to form a larger, more powerful array. Essentially, this prototype shows a small-scale version of both our technology and its housing. The completion of this initial prototype design marks another milestone in our path to commercializing our nanoparticle technology. We look forward to sharing additional updates with our shareholders and supporters as we continue working toward our 2022 goals.”
Earlier this year HYSR shared its 2022 targets which include:
On March 28, SunHydrogen shared a Q1 update detailing the developmental milestones required for a production-quality prototype of the company’s nanoparticle-based green hydrogen technology by the end of Q4 2022. These targets included:
- Successful fabrication of semiconductor units at production-quality prototype scales
- Successful integration of membranes at production-quality prototype scales
- Successful integration of catalysts at production-quality prototype scales
- Successful testing and demonstration of production-quality prototype units
SunHydrogen is pleased to share that it remains on track to demonstrate a production-quality prototype of its nanoparticle-based green hydrogen technology by the end of Q4 2022.
Today we shared a first look at the prototype design for our forthcoming nanoparticle-based green hydrogen technology. View the images and learn more about the design below: https://t.co/YLKxjLB3AU
— SunHydrogen (@SunHydrogenInc) September 6, 2022
For more on HYSR Subscribe Right Now!
Currently trading at a $146 million market valuation HSYR has 4.2 billion out of 10 billion authorized shares outstanding. The Company is well funded moving forward with $42 million in the treasury and $7.4 million in marketable securities on $39.5 million in liabilities and the Company is pre revenue. HYSR is an exciting story developing in small caps addressing a booming hydrogen generation market size which was USD 142.33 billion in 2019 and is projected to reach USD 208.86 billion by 2027 and a trillion by 2050. SunHydrogen continues to make progress toward multiple planned 2022 milestones and is on track to demonstrate a production-quality prototype of its nanoparticle-based green hydrogen technology by the end of Q4 2022. Last week the Company provided a first look at the prototype design for its forthcoming nanoparticle-based green hydrogen technology. The images can be viewed by visiting the Company’s news feed. Microcapdaily covered HSYR in our article (Sunhydrogen Inc (OTCMKTS: HYSR) A Rising Bull) on July 29, 2020 when the stock was sub $0.01 just as it was taking off on its run to $0.34 highs in early 2021 and we will be updating on HSYR so make sure you are subscribed to Microcapdaily.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in HYSR either long or short and we have not been compensated for this article.
Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.
“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”
$ACON Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
— TheStockDon (@TheStockDon) May 30, 2023
More on Nociscan Technology
Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.
$ACON Watching for volume and run. Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
— David Kang (@realtraderkang) May 30, 2023
What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers.
To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.
https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20
Nociscan Study
They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.
Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”
$ACON Watching for volume and run. Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
— David Kang (@realtraderkang) May 30, 2023
It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.
$ACON 5.9M float https://t.co/Ff15RnAMTA
— TheStockDon (@TheStockDon) May 30, 2023
Conclusion
The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.
We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.
Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.
this one went huge………..
$AMTX 370 https://t.co/Rbq3hnf6uM
— Sandman (@Sandman7591) May 19, 2023
They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.
$Amtx EPA approved kaboom another winner from rara koko private discord – we know the news and catalyst first stamp now 1025am 5/19/23 alert sent to subscribers cell phone all over the world -super fast super quick. pic.twitter.com/2RVHENSnqd
— rara koko (@rarakoko3) May 19, 2023
They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.
To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.
Aemetis Setting Up For Short Squeeze $AMTX #stockstowatch #StockMarket #investment https://t.co/41OT89vgod pic.twitter.com/kDDKAHb9b0
— Kirk Spano (@KirkSpano) May 18, 2023
The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.
Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.
https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20
Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?
The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.
(told ya) Aemetis Setting Up For Short Squeeze $AMTX our 1-year price target is $17 to $22 https://t.co/kMxOgQYEk2
— Kirk Spano (@KirkSpano) May 18, 2023
The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.
The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies.
The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.
We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Image by Leopold Böttcher from Pixabay
Emerging Markets
GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing
GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.
So what happened, and what drove the stock to trade 50M shares with filings or news releases?
After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.
$GSIT no news I see . correct if im wrong
— S3NZU (@tech_watchlist) May 12, 2023
With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.
$GSIT GSIT +64% this am: Number one pick for AI on stew varney fox business moments ago. Analyst said if your broker recommends Invidia fire them this is the company that could be leader of the world and AI.
— Van Hutcherson (@vhutcherson) May 12, 2023
This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.
https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20
This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.
To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.
$GSIT been doing this a long time & always makes me laugh
NO one wanted GSIT at $1.50 or CASH on hand but killing it at $3.20 $$$Congrats to those that bought on the cheap & @super_trades for great DD https://t.co/M6fMQ2Aotj
— Pmony (@pmony5) May 12, 2023
GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.
To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.
The best AI play, $gsit don’t miss out pic.twitter.com/gGyryTXqNj
— wickmen (@wickmen) May 12, 2023
By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.
$GSIT earnings May 16 after the market close. Low volume domestic semi conductor. My favorite sector. I have buys at 1.60 and 1.64
— Woolz (@WoolseyCraig) May 11, 2023
In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.
We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Image by Gerd Altmann from Pixabay
LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum
Reunion Neuroscience Inc.’s (NASDAQ: REUN) Take-Private Agreement and Its Impact on Mental Health Solutions
Marker Therapeutics, Inc. (NASDAQ: MRKR) Unveils Exciting Pre-Clinical Findings of MT-601 T Cell Therapy in Lymphoma Cells
Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership
Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI
-
Uncategorized6 months agoMeta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)
-
Micro Cap Insider2 years agoMedium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)
-
Media & Technology2 years agoHealthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward
-
Media & Technology3 years ago
AMECA Mining RM; the Rise of Southcorp Capital, Inc. (OTCMKTS: STHC)
-
Media & Technology2 years agoSNPW (Sun Pacific Holding Corp) Power Brewing: 50MW solar farm project in Durango Mexico MOU with Atlas Medrecycler 48,000 SF New Partnership Queensland Australia Solar Farm.
-
BioPharma1 year agoAsia Broadband (OTCMKTS: AABB) On the Move Northbound Since Sub $0.08 Dip as Crypto Innovator Elevates AABB Crypto Exchange & Enters the NFT Space
-
Uncategorized7 months agoMeta Materials Inc (OTCMKTS: MMTLP) Short Squeeze S-1a4 Filing Signals S1 Approval Could Be Days Away (Next Bridge Hydrocarbons Spin-Off)
-
BioPharma2 years agoHumbl Inc (OTCMKTS: HMBL) Major Reversal as Powerful Advisor Rejoins the Team & Looks to Uplist to Major Exchange
